Search by Drug Name or NDC

    NDC 42494-0309-03 Amiodarone HCl 400 mg/1 Details

    Amiodarone HCl 400 mg/1

    Amiodarone HCl is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cameron Pharmaceuticals, LLC. The primary component is AMIODARONE HYDROCHLORIDE.

    Product Information

    NDC 42494-0309
    Product ID 42494-309_d332d9a4-d658-5637-e053-2a95a90ae403
    Associated GPIs 35400005000320
    GCN Sequence Number 047421
    GCN Sequence Number Description amiodarone HCl TABLET 400 MG ORAL
    HIC3 A2A
    HIC3 Description ANTIARRHYTHMICS
    GCN 12465
    HICL Sequence Number 000083
    HICL Sequence Number Description AMIODARONE HCL
    Brand/Generic Generic
    Proprietary Name Amiodarone HCl
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amiodarone Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 400
    Active Ingredient Units mg/1
    Substance Name AMIODARONE HYDROCHLORIDE
    Labeler Name Cameron Pharmaceuticals, LLC
    Pharmaceutical Class Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077069
    Listing Certified Through 2022-12-31

    Package

    NDC 42494-0309-03 (42494030903)

    NDC Package Code 42494-309-03
    Billing NDC 42494030903
    Package 30 TABLET in 1 BOTTLE (42494-309-03)
    Marketing Start Date 2018-03-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.74861
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description AMIODARONE HCL 400 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis